Acadia Healthcare Company Past Earnings Performance
Past criteria checks 3/6
Acadia Healthcare Company has been growing earnings at an average annual rate of 18.4%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 10.2% per year. Acadia Healthcare Company's return on equity is 9.2%, and it has net margins of 9%.
Key information
18.4%
Earnings growth rate
18.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 10.2% |
| Return on equity | 9.2% |
| Net Margin | 9.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Acadia Healthcare Company makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,123 | 281 | 236 | 0 |
| 30 Jun 24 | 3,057 | -5 | 232 | 0 |
| 31 Mar 24 | 2,993 | -11 | 228 | 0 |
| 31 Dec 23 | 2,929 | -22 | 223 | 0 |
| 30 Sep 23 | 2,861 | -18 | 217 | 0 |
| 30 Jun 23 | 2,778 | 271 | 212 | 0 |
| 31 Mar 23 | 2,698 | 278 | 208 | 0 |
| 31 Dec 22 | 2,610 | 273 | 203 | 0 |
| 30 Sep 22 | 2,529 | 282 | 196 | 0 |
| 30 Jun 22 | 2,449 | 277 | 190 | 0 |
| 31 Mar 22 | 2,380 | 242 | 182 | 0 |
| 31 Dec 21 | 2,314 | 203 | 175 | 0 |
| 30 Sep 21 | 2,262 | 192 | 169 | 0 |
| 30 Jun 21 | 2,223 | 162 | 163 | 0 |
| 31 Mar 21 | 2,132 | 144 | 159 | 0 |
| 31 Dec 20 | 2,090 | 140 | 158 | 0 |
| 30 Sep 20 | 1,230 | 14 | 34 | 0 |
| 30 Jun 20 | 1,459 | 20 | 78 | 0 |
| 31 Mar 20 | 1,757 | 41 | 117 | 0 |
| 31 Dec 19 | 2,008 | 52 | 154 | 0 |
| 30 Sep 19 | 3,071 | -211 | 319 | 0 |
| 30 Jun 19 | 3,054 | -208 | 316 | 0 |
| 31 Mar 19 | 3,031 | -197 | 311 | 0 |
| 31 Dec 18 | 1,905 | 57 | 144 | 0 |
| 30 Sep 18 | 2,993 | 226 | 300 | 0 |
| 30 Jun 18 | 2,949 | 225 | 293 | 0 |
| 31 Mar 18 | 2,899 | 216 | 285 | 0 |
| 31 Dec 17 | 2,836 | 200 | 273 | 0 |
| 30 Sep 17 | 2,815 | 172 | 266 | 0 |
| 30 Jun 17 | 2,833 | 9 | 261 | 0 |
| 31 Mar 17 | 2,873 | 15 | 266 | 0 |
| 31 Dec 16 | 2,811 | 6 | 259 | 0 |
| 30 Sep 16 | 2,603 | -1 | 236 | 0 |
| 30 Jun 16 | 2,348 | 146 | 208 | 0 |
| 31 Mar 16 | 2,046 | 124 | 175 | 0 |
| 31 Dec 15 | 1,794 | 112 | 149 | 0 |
| 30 Sep 15 | 1,594 | 100 | 126 | 0 |
| 30 Jun 15 | 1,409 | 96 | 104 | 0 |
| 31 Mar 15 | 1,169 | 85 | 80 | 0 |
| 31 Dec 14 | 1,005 | 83 | 65 | 0 |
| 30 Sep 14 | 900 | 73 | 58 | 0 |
| 30 Jun 14 | 790 | 62 | 51 | 0 |
| 31 Mar 14 | 754 | 52 | 49 | 0 |
| 31 Dec 13 | 713 | 43 | 47 | 0 |
Quality Earnings: 7RA has high quality earnings.
Growing Profit Margin: 7RA became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7RA has become profitable over the past 5 years, growing earnings by 18.4% per year.
Accelerating Growth: 7RA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 7RA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: 7RA's Return on Equity (9.2%) is considered low.